Litcius/Paper detail

Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLC

Ha-Ram Park, Tae Min Kim, Yusoo Lee, Soyeon Kim, Seongyeol Park, Young Seok Ju, Miso Kim, Bhumsuk Keam, Yoon Kyung Jeon, Dong‐Wan Kim, Dae Seog Heo

2021Journal of Thoracic Oncology27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMutantAcquired resistanceTyrosine kinaseCancer researchInternal medicineGeneticsGeneReceptorCancerBiologyLung Cancer Treatments and MutationsHER2/EGFR in Cancer ResearchColorectal Cancer Treatments and Studies
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFRT790M-Mutant NSCLC | Litcius